Day 1
7:30
Registration & Continental Breakfast
8:45
Chairman's Opening Remark's
David Rabuka, Global Head of R & D, Catalent Pharma Solutions
9:00
Greg Bleck, Ph.D.
Optimization of Titers and a Specific Enzyme Conversion Step to Generate Fully Processed Antibody in CHO Cells
9:30
Celltheon SMART Expression platform for stable long term expression of next generation Biologics and Biosimilar Molecules
Amita Goel, Founder & CEO, Celltheon Corporation
10:00
Switchable Membrane Reporter ( SwiMR) technology for facile bio production and cell line development
Bo Yu, CSO, Larix Biosciences
10:30
SHAHRAM MISAGHI, PHD
To Fucosylate or Not: Utilizing FX knock CHO Lines to Express Fucosylated or Afucosylated Antibodies on Command
Day 2
7:30
Continental Breakfast & Networking
8:45
Chairman's Opening Remarks
Dr. Sarfaraz K. Niazi, Ph.D
9:00
Bill Whitford
Clone Specific improvement in productivity and glycosylation fidelity
9:30
Next Generation Monoclonal Antibody Development using Modified Cellular Platform
Dr. Maloy Gosh, Ph.D., CSO, Theramyt Novobiologics
10:00
Dr. Michiel E. Ultee